Patricia L. Kavanagh, MD
Associate Professor
Boston University School of Medicine
Dept of Pediatrics
General Pediatrics

MD, Boston University

Dr. Kavanagh has a national reputation in systems approaches to improve the care of children and adults with sickle cell disease (SCD). The Quality Lead for the Department of Pediatrics, and attending physician in the BMC Pediatric ED, she and colleagues defined and refined treatment standards for children with sickle cell disease, relevant to the Boston-area patient population but also globally. Her federal grants include a K23 from the National Heart, Lung and Blood Institute. She led the Health Resources and Services Administration’s (HRSA’s) Sickle Cell Disease Newborn Screening Program at BMC. Nationally she Co-Founded and Chaired the Taskforce for Emergency Department Sickle Cell Care Collaborative and serves on the Oversight Steering Committee of HRSA’s Sickle Cell Disease Treatment Demonstration Program, its Data and Measurement Workgroup, the Steering Committee for the American Society of Hematology’s Sickle Cell Disease Coalition, and on the national Sickle Cell Disease Council for Change.

Active Staff Privileges
Boston Medical Center

Sickle Cell Treatment Demonstration Program
09/01/2017 - 08/31/2019 (PI)
Johns Hopkins University HRSA

Eleminating suffering in the emergency room treatment of sickle cell vaso-occlusive crisis
09/01/2016 - 08/31/2018 (PI)
Georgia Medical Care Foundation Centers for Medicare

Management of Sickle Cell Disease-Related Pain in Children
08/10/2011 - 07/31/2017 (PI)

Patient Navigation in Sickle Cell Disease
06/01/2013 - 05/31/2014 (PI)
University of New Hampshire HRSA

Improving Quality of Care for Children with Sickle Cell Disease
09/01/2009 - 02/25/2011 (PI)
DM Noonan Mem Fund

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Melita N, Diaz-Linhart Y, Kavanagh PL, Sobota A. Developing a Problem-solving Intervention to Improve Self-Management and Transition Readiness in Adolescents with Sickle Cell Disease. J Pediatr Nurs. 2019 May - Jun; 46:26-32.View Related Profiles. PMID: 30826724.
  2. Akinsola B, Hagbom R, Zmitrovich A, Kavanagh PL, Ashkouti A, Simon HK, Fleming A, Jain S, Dampier C, Morris CR. Impact of Intranasal Fentanyl in Nurse Initiated Protocols for Sickle Cell Vaso-occlusive Pain Episodes in a Pediatric Emergency Department. Am J Hematol. 2018 May 17. PMID: 29770479.
  3. Lewen MO, Kavanagh PL, Sobota AE. A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia. Am J Hematol. 2017 06; 92(6):E121-E122.View Related Profiles. PMID: 28335074; DOI: 10.1002/ajh.24727;.
  4. Kavanagh PL, Sprinz PG, Wolfgang TL, Killius K, Champigny M, Sobota A, Dorfman D, Barry K, Miner R, Moses JM. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department. Pediatrics. 2015 Oct; 136(4):e1016-25.View Related Profiles. PMID: 26391933; DOI: 10.1542/peds.2014-3470;.
  5. Sobota AE, Kavanagh PL, Adams WG, McClure E, Farrell D, Sprinz PG. Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic. Pediatr Blood Cancer. 2015 Apr; 62(4):654-7.View Related Profiles. PMID: 25545967; DOI: 10.1002/pbc.25390;.
  6. Walsh KE, Cutrona SL, Kavanagh PL, Crosby LE, Malone C, Lobner K, Bundy DG. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014 Dec; 134(6):1175-83. PMID: 25404717; PMCID: PMC4243064; DOI: 10.1542/peds.2014-0177;.
  7. Taylor C, Kavanagh P, Zuckerman B. Sickle cell trait--neglected opportunities in the era of genomic medicine. JAMA. 2014 Apr 16; 311(15):1495-6.View Related Profiles. PMID: 24604073; DOI: 10.1001/jama.2014.2157;.
  8. Parker MG, Barrero-Castillero A, Corwin BK, Kavanagh PL, Belfort MB, Wang CJ. Pasteurized human donor milk use among US level 3 neonatal intensive care units. J Hum Lact. 2013 Aug; 29(3):381-9.View Related Profiles. PMID: 23764482; DOI: 10.1177/0890334413492909;.
  9. Chawla A, Sprinz PG, Welch J, Heeney M, Usmani N, Pashankar F, Kavanagh P. Weight status of children with sickle cell disease. Pediatrics. 2013 Apr; 131(4):e1168-73.View Related Profiles. PMID: 23460681; DOI: 10.1542/peds.2012-2225;.
  10. Kenyon CC, Kavanagh PL, Fiechtner LG, Textor TE, Wang CJ. Setting the agenda for quality improvement in pediatric sickle cell disease. J Natl Med Assoc. 2012 Jul-Aug; 104(7-8):337-41. PMID: 23092048.
Showing 10 of 20 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 20 publications over 13 distinct years, with a maximum of 3 publications in 2011 and 2014

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

health services research
quality indicators
quality of care
sickle cell disease

I have mentored fellows, residents and students in research projects, with most concentrated on issues relevant to individuals living with sickle cell disease.

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

88 E. Newton St Vose Hall
Boston MA 02118
Google Map

Kavanagh's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department